Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
McKesson
Teva
Farmers Insurance
Medtronic
Fish and Richardson
Dow
Julphar
Queensland Health
Moodys

Generated: December 12, 2017

DrugPatentWatch Database Preview

Apopharma Inc Company Profile

« Back to Dashboard

What is the competitive landscape for APOPHARMA INC, and when can generic versions of APOPHARMA INC drugs launch?

APOPHARMA INC has two approved drugs.

There are two US patents protecting APOPHARMA INC drugs on APOPHARMA INC drugs in the past three years.

There are thirty-seven patent family members on APOPHARMA INC drugs in twenty-four countries.

Summary for Apopharma Inc

International Patents:37
US Patents:2
Tradenames:1
Ingredients:1
NDAs:2
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Exclusivity Expiration
Apopharma IncFERRIPROXdeferiproneTABLET;ORAL021825-001Oct 14, 2011RXYesYes► Subscribe► Subscribe► Subscribe► Subscribe
Apopharma IncFERRIPROXdeferiproneSOLUTION;ORAL208030-001Sep 9, 2015RXYesYes► Subscribe► Subscribe► SubscribeY► Subscribe
Apopharma IncFERRIPROXdeferiproneSOLUTION;ORAL208030-001Sep 9, 2015RXYesYes► Subscribe► Subscribe► Subscribe► Subscribe
Apopharma IncFERRIPROXdeferiproneSOLUTION;ORAL208030-001Sep 9, 2015RXYesYes► Subscribe► Subscribe► Subscribe► Subscribe
Apopharma IncFERRIPROXdeferiproneSOLUTION;ORAL208030-001Sep 9, 2015RXYesYes► Subscribe► Subscribe► Subscribe► Subscribe
Apopharma IncFERRIPROXdeferiproneTABLET;ORAL021825-001Oct 14, 2011RXYesYes► Subscribe► Subscribe► Subscribe► Subscribe
Apopharma IncFERRIPROXdeferiproneTABLET;ORAL021825-001Oct 14, 2011RXYesYes► Subscribe► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Paragraph IV activity for APOPHARMA INC drugs

Drugname Dosage Strength Tradename Submissiondate
deferiproneTablets500 mgFERRIPROX1/29/2016

International Patent Family for Apopharma Inc Drugs

Country Document Number Estimated Expiration
Ukraine102254► Subscribe
South Africa200109322► Subscribe
Israel208876► Subscribe
BrazilPI0822206► Subscribe
Eurasian Patent Organization022751► Subscribe
Portugal2268282► Subscribe
Cyprus1109191► Subscribe
Eurasian Patent Organization201071235► Subscribe
Hong Kong1130422► Subscribe
European Patent Office2268282► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
Here is a list of applicants with similar names.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Novartis
Express Scripts
Federal Trade Commission
Cerilliant
Boehringer Ingelheim
QuintilesIMS
UBS
Harvard Business School
Julphar

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot